Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...

A new study reveals a strange light-brown slime on Indian River Lagoon dolphins signals suppressed immunity and other health issues.

YCANTH® net revenue grew 130% to $15.3 million in 2025, and selling, general and administrative expenses decreased by over 40 ...

Rates infection related cancer have increased among solid organ transplant recipients, CDC reports a five-fold rise in Kaposi sarcoma virus transmission.

YCANTH® net revenue grew 130% to $15.3 million in 2025, and selling, general and administrative expenses decreased by over 40%, when compared to 2024 - - Company earned $35.6 million in total revenue ...

Though high rates of the disease persist among the nearby Indigenous communities, the Canadian government is weighing rules that may allow energy giants to release treated mining waste into the river ...

Clarity Pharmaceuticals ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Menopause comes with a lot of symptoms hot flashes and night sweats among the more well-known. But there are many other ways the hormonal changes of menopause affect your body, including your skin.

Meet 5 hot biotechs in Arizona, from Phoenix to Tucson, that have raised significant funding over the past decade.

Back in the late 1800s, medicine didn't have all the answers. People died from infections that today we might cure with pills. And then there was Niels Ryberg Finsen, a doctor from Denmark, who ...

IDEXX Laboratories IDXX has shown strong momentum in the last 12 months, rising 39.4%. The stock has comfortably surpassed the industry’s 4.3% decline and the S&P 500 Composite’s 23.1% return.